Drug Discovery
Innovation Programme

BenevolentAI builds agent-native tools that support critical decision-making in R&D. Its next generation life science intelligence platform helps scientists and executives navigate complex data with clarity and confidence, turning information into actionable insights that guide strategy and accelerate discovery.

Merck KGaA, Darmstadt, Germany, is a global science and technology company with a rich history of innovation. With approximately 63,000 employees, we operate in three main sectors: Healthcare, Life Science, and Electronics. Our Life Science division, including Sigma-Aldrich, offers a comprehensive range of chemicals, lab solutions, and services designed to support research and development across various fields. Committed to advancing health and technology, we strive to enhance the quality of life while making a positive impact on society and the environment.

CAS, the world leader in scientific information, offers powerful analytical and predictive solutions fully integrated with reliable chemistry and biology data. With the new CAS BioFinder Discovery Platform™, unlock deeper drug discovery insights faster than ever and advance drug discovery with confidence.

Certest Pharma focuses on advanced Drug Delivery through lipid nanoparticles (LNPs), offering a comprehensive platform for RNA vaccines and oligonucleotide therapeutics. The company specializes in proprietary ionizable lipids, key to creating thermostable and highly efficient LNPs. With a library of over 1500 screened lipids, Certest designs tailored formulations for optimal biodistribution and passive or active targeting. Certest LNPs support both systemic and targeted delivery of RNA drugs. This expertise is complemented by in-house Oligonucleotide and RNA capabilities, from design to production, including proprietary UTR sequences, codon optimization tools, and custom enzyme manufacturing for mRNA/saRNA/circRNA synthesis.

CARBOGEN AMCIS provides drug development and commercialisation services to the pharmaceutical and biopharmaceutical industries, at all stages of drug development. Our capabilities span from contract chemical process research and development to the supply of Active Pharmaceutical Ingredients (APIs) - as well as drug products for preclinical studies, clinical trials and commercial use. Besides being a service provider we also offer high quality Cholesterol and Vitamin D analog products produced at our facility in The Netherlands. Our focus is to help customers create a better world by becoming the partner of choice for development and manufacture.

LGC - Your Trusted Partner for Reference Standards

For over 40 years, LGC has been at the forefront of complex organic synthesis, providing high-quality products and services to meet demanding analytical needs. Backed by a catalogue of over 150,000 compounds and industry-leading expertise in stable isotope-labelled (SIL) materials, we provide tailored solutions to support your goals.

Our product portfolio includes API standards, metabolites, impurities, and endogenous compounds, available in native and SIL forms.

Our Specialities:

• Toxicology support: Enabling trace-level analysis and pharmacokinetic studies with bulk synthesis of drug standards and development of SIL materials.
• Custom synthesis: Bespoke synthetic solutions to accelerate lead optimisation.
• Bespoke productions: Flexible unit sizes, customisable Certificates of Analysis, pharmacopeia traceability, and worldwide inventory management.

At LGC, we are committed to being your trusted partner, delivering essential products and services to advance drug discovery, safety evaluations, and pharmaceutical manufacturing.

LGC – Science for a Safer World

Novalix is a premier contract research organization, dedicated to improving the critical early stages of drug discovery by combining exceptional scientific talent and exclusive technology with a comprehensive portfolio of world-class chemistry, biophysics and pharmacology capabilities. We work collaboratively with our clients to meet the most complex scientific challenges, and our innovative partnerships with leading instrument makers and academic institutions help us continually expand the possibilities of human health.

As a global leader in research chemical manufacturing, BLDpharm has been driving innovation in drug discovery since 2014. We offer an extensive catalog of over 1.3 million chemicals, including heterocycles, advanced intermediates, boronic acids, amino acids, metal catalysts, and chiral compounds, serving more than 10,000 customers across 120+ countries. With 120,000 in-stock compounds and a 10,000-square-meter R&D center, we specialize in Custom Synthesis and Scale-up Manufacturing services, catering to the unique needs of our clients. Our expert team, robust supply chains, and ISO-certified management ensure the highest standards of quality and efficiency. At BLDpharm, we’re committed to accelerating the future of drug discovery by providing cutting-edge solutions and unwavering support to researchers and scientists worldwide.

Collaborative Drug Discovery (CDD) provides an intuitive software suite extensively used by creative biologists and chemists working in academic, biotechnology and pharmaceutical settings. Their flagship product, CDD Vault, enables researchers to intuitively organize and analyze both biological and chemical data, and to collaborate with partners through a straightforward web interface. CDD Vault helps scientists register entities, track inventory, manage bioassay data, capture experiments, calculate Structure-Activity Relationships (SAR), and mine their data for drug candidates. It also functions as an Electronic Laboratory Notebook (ELN) to capture and share experimental results. CDD Vault is differentiated through its intuitive design, superior performance, and workflows for secure, collaborative data sharing capabilities. CDD was founded in 2004 and presently serves thousands of researchers doing drug discovery all around the world.

Sai Life Sciences is a fast-growing global Contract Research, Development & Manufacturing Organization (CRDMO). We work with innovator biotech and pharma companies to accelerate the discovery, development and commercialization of complex small molecules. With over 3000 employees across our facilities in UK, USA and India, we support innovators across the entire drug discovery journey from concept to commercialisation, including exploratory biology, creative chemistry, DMPK, toxicology, early phase development, process & analytical development, scale-up, tech transfer, clinical supplies, and cGMP manufacturing. We serve over 300 innovators, spanning start-ups, small & mid-sized pharma, and large pharma companies and count among our clients 18 of the top 25 large pharma companies. Over the past 25+ years, we have built our business on the foundation of mutual trust and client focus, consistently delivering value based on our scientific strength and responsiveness.

IRBM is a scientific contract research organization (CRO) that stands at the forefront of drug discovery, leveraging a single, unified research facility to accelerate team-based breakthroughs and improve efficiencies from concept to candidate. With a history of contributing to several approved drugs, and its own internal pipeline of oncology and other therapeutic assets, IRBM is powered by deep collaborations and decades of expertise from leading global institutions. Their comprehensive in-house capabilities assist partners in achieving key milestones and progressing towards clinical readiness, positioning IRBM as a major player in driving innovation in the pharmaceutical and biotech fields.

Contact Information:

For further information, please contact us: bd@irbm.com

Gene Therapy Net is the information resource for basic and clinical research in gene therapy, and the site serves as a network for the exchange of gene therapy information and breaking news items. Visitors can keep track of the latest scientific papers, conference announcements, gene therapy jobs, regulations and guidelines.

BioPartner UK is the independent trade organisation that supports UK companies to do business internationally. BioPartner works with conference organisers, in-country agencies, overseas networks and the UK government Dept for Business and Trade, to provide the best business opportunities for our members and UK based companies in the Life Science sector.

Lonza is one of the world’s largest contract development and manufacturing organizations (CDMOs), dedicated to serving the healthcare industry. We work alongside a broad range of customers – from emerging biotechs to global pharmaceutical companies – to transform their therapeutic discoveries into life-saving and life-enhancing treatments for their patients. Our business is structured to meet our customers’ complex needs across three synergistic Business Platforms: Integrated Biologics, Advanced Synthesis and Specialized Modalities. In Advanced Synthesis, we apply more than 125 years’ of expertise in classic and complex chemistry to the manufacturing of small molecules, highly potent APIs, antibody-drug conjugates and bioconjugates. Advanced Synthesis leverages custom organic synthesis services and established technologies to enable innovative therapies.

MEDizzy is one of the fastest-growing online medical communities in the world, bringing together over 10 million medical students, doctors, and healthcare professionals. Our mission is to democratize access to medical knowledge through innovative educational tools, mobile apps, and engaging multimedia content.